ESMO Breast Cancer 2026 Highlights: SERENA-6 - Top-Institutions - MDSpire

ESMO Breast Cancer 2026 Highlights: SERENA-6

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the SERENA-6 trial, which were presented at the 2026 ESMO Breast Cancer Congress.

June 26, 2026

Dana-Farber

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Institut Curie

Paris, Île-de-France
Key Differentiators
- Breast Cancer
- Oncology
#2

The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research (ICR)

London, United Kingdom
Key Differentiators
- Breast Cancer
- Oncology